COMPARE · Reviewed July 2, 2026

APP vs META

Verdict: Side-by-side breakdown using the Bull Rankings model. APP scored 72.9, META scored 82.2 — META ahead by 9.299999999999997.
APP
AppLovin Corporation
Advertising Agencies · Quality-Growth
72.9
$527.06
Score gap
9.299999999999997
META leads
META
Meta Platforms, Inc.
Internet Content & Information · Quality-Growth
82.2
$582.90
APPAppLovin Corporation
Advertising Agencies · $527.06 · beta 2.46
Why now
Advertising Agencies · market cap $177.1b. Down 29% from 52-week high of $745.61 — deep drawdown territory. Revenue growing +70% — in hypergrowth territory. 30 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $654.47 (implying +24% upside).
Moat
Net margin 64% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. FCF converts 112% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined. $177.1b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Beta 2.46 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Trailing P/E 46x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. P/S 28.7x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
METAMeta Platforms, Inc.
Internet Content & Information · $582.90 · beta 1.23
Why now
Internet Content & Information · market cap $1.5T. Down 27% from 52-week high of $796.25 — deep drawdown territory. Revenue growing +22%, comfortably above the S&P median. PEG 0.81 — paying under fair value for the growth rate. 58 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $828.13 (implying +42% upside).
Moat
Net margin 33% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 29% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. $1.5T market cap places it among the largest companies in the sector — distribution, R&D, and customer-acquisition costs amortize across a base peers can't replicate.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
APPComponentMETA
B80FCFA95
A95RevA-90
C65D/EB+85
C65P/E or P/SB80
B80PEGB+85
Supplemental signals · feed the score, not on the row card
C+70FCF YieldB80
C65ROEA-90
76.7Base composite85.9
APP
hypergrowth premium (rev +70%)+2
analyst consensus bullish (91% buy/strong-buy)+2
forward P/E cheaper (46 → 24)+1
DCF cross-check (avg upside -64%)-2
ROE truncated (buyback-depleted equity)-1
Total+2
META
GARP sweet spot (PEG <1, positive FCF)+1
analyst consensus bullish (90% buy/strong-buy)+2
DCF cross-check (avg upside -50%)-1
Total+2
APP upsideHorizonMETA upside
-74%1Y-56%
-66%5Y-51%
-52%10Y-42%
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.